Tracking tumor heterogeneity and progression with near‐infrared II fluorophores

Abstract Heterogeneous cells are the main feature of tumors with unique genetic and phenotypic characteristics, which can stimulate differentially the progression, metastasis, and drug resistance. Importantly, heterogeneity is pervasive in human malignant tumors, and identification of the degree of...

Full description

Bibliographic Details
Main Authors: Qi Xin, Huizhen Ma, Hao Wang, Xiao‐Dong Zhang
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Exploration
Subjects:
Online Access:https://doi.org/10.1002/EXP.20220011
_version_ 1797842820005888000
author Qi Xin
Huizhen Ma
Hao Wang
Xiao‐Dong Zhang
author_facet Qi Xin
Huizhen Ma
Hao Wang
Xiao‐Dong Zhang
author_sort Qi Xin
collection DOAJ
description Abstract Heterogeneous cells are the main feature of tumors with unique genetic and phenotypic characteristics, which can stimulate differentially the progression, metastasis, and drug resistance. Importantly, heterogeneity is pervasive in human malignant tumors, and identification of the degree of tumor heterogeneity in individual tumors and progression is a critical task for tumor treatment. However, current medical tests cannot meet these needs; in particular, the need for noninvasive visualization of single‐cell heterogeneity. Near‐infrared II (NIR‐II, 1000–1700 nm) imaging exhibits an exciting prospect for non‐invasive monitoring due to the high temporal‐spatial resolution. More importantly, NIR‐II imaging displays more extended tissue penetration depths and reduced tissue backgrounds because of the significantly lower photon scattering and tissue autofluorescence than traditional the near‐infrared I (NIR‐I) imaging. In this review, we summarize systematically the advances made in NIR‐II in tumor imaging, especially in the detection of tumor heterogeneity and progression as well as in tumor treatment. As a non‐invasive visual inspection modality, NIR‐II imaging shows promising prospects for understanding the differences in tumor heterogeneity and progression and is envisioned to have the potential to be used clinically.
first_indexed 2024-04-09T16:54:27Z
format Article
id doaj.art-1477719f8b2d47e6b3289622d926c075
institution Directory Open Access Journal
issn 2766-8509
2766-2098
language English
last_indexed 2024-04-09T16:54:27Z
publishDate 2023-04-01
publisher Wiley
record_format Article
series Exploration
spelling doaj.art-1477719f8b2d47e6b3289622d926c0752023-04-21T06:15:01ZengWileyExploration2766-85092766-20982023-04-0132n/an/a10.1002/EXP.20220011Tracking tumor heterogeneity and progression with near‐infrared II fluorophoresQi Xin0Huizhen Ma1Hao Wang2Xiao‐Dong Zhang3Tianjin Key Laboratory of Brain Science and Neural Engineering Academy of Medical Engineering and Translational Medicine, Tianjin University Tianjin ChinaDepartment of Physics and Tianjin Key Laboratory of Low Dimensional Materials Physics and Preparing Technology, School of Sciences Tianjin University Tianjin ChinaTianjin Key Laboratory of Brain Science and Neural Engineering Academy of Medical Engineering and Translational Medicine, Tianjin University Tianjin ChinaTianjin Key Laboratory of Brain Science and Neural Engineering Academy of Medical Engineering and Translational Medicine, Tianjin University Tianjin ChinaAbstract Heterogeneous cells are the main feature of tumors with unique genetic and phenotypic characteristics, which can stimulate differentially the progression, metastasis, and drug resistance. Importantly, heterogeneity is pervasive in human malignant tumors, and identification of the degree of tumor heterogeneity in individual tumors and progression is a critical task for tumor treatment. However, current medical tests cannot meet these needs; in particular, the need for noninvasive visualization of single‐cell heterogeneity. Near‐infrared II (NIR‐II, 1000–1700 nm) imaging exhibits an exciting prospect for non‐invasive monitoring due to the high temporal‐spatial resolution. More importantly, NIR‐II imaging displays more extended tissue penetration depths and reduced tissue backgrounds because of the significantly lower photon scattering and tissue autofluorescence than traditional the near‐infrared I (NIR‐I) imaging. In this review, we summarize systematically the advances made in NIR‐II in tumor imaging, especially in the detection of tumor heterogeneity and progression as well as in tumor treatment. As a non‐invasive visual inspection modality, NIR‐II imaging shows promising prospects for understanding the differences in tumor heterogeneity and progression and is envisioned to have the potential to be used clinically.https://doi.org/10.1002/EXP.20220011bioimagingNIR‐II fluorophorestumor heterogeneitytumor progression
spellingShingle Qi Xin
Huizhen Ma
Hao Wang
Xiao‐Dong Zhang
Tracking tumor heterogeneity and progression with near‐infrared II fluorophores
Exploration
bioimaging
NIR‐II fluorophores
tumor heterogeneity
tumor progression
title Tracking tumor heterogeneity and progression with near‐infrared II fluorophores
title_full Tracking tumor heterogeneity and progression with near‐infrared II fluorophores
title_fullStr Tracking tumor heterogeneity and progression with near‐infrared II fluorophores
title_full_unstemmed Tracking tumor heterogeneity and progression with near‐infrared II fluorophores
title_short Tracking tumor heterogeneity and progression with near‐infrared II fluorophores
title_sort tracking tumor heterogeneity and progression with near infrared ii fluorophores
topic bioimaging
NIR‐II fluorophores
tumor heterogeneity
tumor progression
url https://doi.org/10.1002/EXP.20220011
work_keys_str_mv AT qixin trackingtumorheterogeneityandprogressionwithnearinfrarediifluorophores
AT huizhenma trackingtumorheterogeneityandprogressionwithnearinfrarediifluorophores
AT haowang trackingtumorheterogeneityandprogressionwithnearinfrarediifluorophores
AT xiaodongzhang trackingtumorheterogeneityandprogressionwithnearinfrarediifluorophores